2002

Retaining Members in California's County-Level HIV-Prevention Community Planning Groups
AIDS & Public Policy Journal 17, no. 4 (Winter 2002) 153-160
Grace L. Reynolds, Dennis G. Fisher, Jennifer A. Klahn, and Biren Shukla
The objective of this project was to study how well HIV-prevention-planning local implementation groups (LIGs) in 24 counties in California retained their members. We stratified LIGs by whether their co-chair perceived that her or his group had trouble retaining its members. Of the 24 groups, nine LIGs whose co-chairs


Risks of HIV Transmission and the 100 Percent Condom Use Program: A Comparative Study of HIV-Prevention Programs in Thailand and in India
AIDS & Public Policy Journal 17, no. 4 (Winter 2002) 135-152
Gauri Bhattacharya
The development of an effective strategy to prevent HIV infection involves drawing on evidence-based methods, learning from the practices of other countries, and adapting the practices to local circumstances within a particular country s socio-cultural and national contexts. In its comprehensive condom use program, the


If There's a Will, Is There a Way? Integrating HIV and Mental Health Services in Rural Areas
AIDS & Public Policy Journal 17, no. 4 (Winter 2002) 127-134
Kimberly Scott, Trang Quyen Nguyen, and Kathryn Whetten
In North Carolina, more than 50,000 of the 84,000 people with serious mental illness who need services from the community-based health system or the public mental health system are not served.1 In the 1990s, federal authorities investigated the state s Medicaid mental health funding after reports of multi-million dolla


Pharmacy Access to Over-the-Counter Syringes in Connecticut: Implications for HIV and Hepatitis Prevention among Injection-Drug Users
AIDS & Public Policy Journal 17, no. 4 (Winter 2002) 115-126
Thomas J. Stopka, Merrill Singer, Wei Teng, Joseph Horton, and Wilson Compton,III
Injection-drug use is implicated as one of the primary causes of HIV and hepatitis transmission. Sharing of previously used and potentially contaminated syringes by injection-drug users (IDUs) has a cascade effect on communities, and places IDUs, their sexual partners, and related infants at increased risk for acquirin


Young People and HIV/AIDS: The Need for a Continuum of Care: Findings and Policy Recommendations from Nine Adolescent-Focused Projects
AIDS & Public Policy Journal 17, no. 3 (Fall 2002) 90-111
Elizabeth R. Woods, Cathryn L. Samples, Barney Singer, Nadine P. Peters, Lee A. Trevithick, Arlene Schneir, Steven Tierney, Rudy Feudo, Gilbert Pickett, Eric R. Wright, Gary Remafedi, Brian L. Greenberg, Lisa A. Melchior, and G.J. Huba
To generate research about the provision of care and services for young people affected by HIV/AIDS, the Special Projects of National Significance (SPNS) Program of the HIV/AIDS Bureau in the Health Resources and Services Administration (HRSA) funded a group of adolescent-focused projects in 1993. At the end of 1998, n


HIV Risk Behaviors during Incarceration among Intravenous-Drug Users in Bangkok, Thailand: A Qualitative Approach
AIDS & Public Policy Journal 17, no. 3 (Fall 2002) 77-89
Aumphornpun Buavirat, Rachel Sacks, and Sithisat Chiamwongpaet
The purpose of this study was to collect qualitative pilot data pertaining to the conditions of HIV risk within correctional facilities in Thailand ; 24 interviews were conducted with men who previously had been in prison and presently were attending a detoxification program at one of the government-run narcotics rehab


How AIDS Became a Race Issue: The Case of Alabama
AIDS & Public Policy Journal 17, no. 2 (Summer 2002) 59-74
Bronwen Lichtenstein
HIV/AIDS in the United States was originally conceptualized as a White man s disease. This perception initially shaped responses to HIV/AIDS on a national and regional basis. It is now recognized that minorities are disproportionately at risk of HIV/AIDS, but policy makers have been slow to address this issue, and prob


HIV Care Consortia and Coverage of Medications
AIDS & Public Policy Journal 17, no. 2 (Summer 2002) 37-58
Robert J. Buchanan and Scott R. Smith
The authors sought to learn how HIV care consortia, funded by Title II of the Ryan White CARE Act, are implemented in each state, and how the consortia help people with HIV receive medications. They surveyed Title II contact people in 1998-1999, regarding eligibility, coordination of consortia and other public programs


Comment: Getting the Most Value Out of a Values History
AIDS & Public Policy Journal 17, no. 1 (Spring 2002) 31-33
O. J. Sahler
Ten of 14 families who were invited agreed to participate in the values-history advance directives interviews that Wissow and colleagues describe in their study. This is a strong signal that these discussions were needed. It is good to have a framework that helps us to have these conversations.


Preliminary Study of a 'Values History' Advance Directive Interview in a Pediatric HIV Clinic
AIDS & Public Policy Journal 17, no. 1 (Spring 2002) 17-30
Lawrence S. Wissow, Nancy Hutton, and Nancy Kass
To facilitate advance-care planning discussions among families and careproviders at our pediatric HIV clinic, we developed a nine-item interview guide, using techniques of medical family therapy. We tested this interview guide with 10 families at the clinic who agreed to participate in the study, including two families


Comment: Disclosing a Diagnosis of HIV to Children: Providing the Best Possible Care
AIDS & Public Policy Journal 17, no. 1 (Spring 2002) 13-16
Steven Hirschfeld
Flanagan-Klygis and colleagues have attempted to address the question of disclosing the diagnosis of HIV to children by comparing the results of two original surveys they conducted, one of parents of HIV-infected children at one medical center, and one of physicians who care for HIV-infected children at many different


Disclosing the Diagnosis of HIV in Pediatrics
AIDS & Public Policy Journal 17, no. 1 (Spring 2002) 3-12
Erin Flanagan-Klygis, Lainie Friedman Ross, John Lantos, Joel Frader, and Ram Yogev
The existing literature reports a high prevalence of non-disclosure of HIV diagnosis to children 4-12 years. Parental reasons for non-disclosure include children s ability to understand information, concern about causing depression, and fears of social stigma and discrimination. In 1999, the American Academy of Pediatr



This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1980, 2002. AEGiS.